Valter Croci
About
In The Last Decade
Valter Croci
9 papers receiving 625 citations
Peers
Comparison fields: 5 of 81
- Molecular Biology 295
- Oncology 285
- Modeling and Simulation 142
- Cell Biology 140
- Cancer Research 85
Countries citing papers authored by Valter Croci
This map shows the geographic impact of Valter Croci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valter Croci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valter Croci more than expected).
Fields of papers citing papers by Valter Croci
This network shows the impact of papers produced by Valter Croci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valter Croci. The network helps show where Valter Croci may publish in the future.
Co-authorship network of co-authors of Valter Croci
This figure shows the co-authorship network connecting the top 25 collaborators of Valter Croci. A scholar is included among the top collaborators of Valter Croci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Valter Croci. Valter Croci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 35 | |
| 2 | 80 | |
| 3 | 1 | |
| 4 | 9 | |
| 5 | 126 | |
| 6 | 10 | |
| 7 | 373 | |
| 8 | In vitro and in vivo characterization of the CDK2 inhibitor PHA-533533 | 2 |
| 9 | Antitumor efficacy of edotecarin in combination with other cytotoxic drugs. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.